Rick Pearson is an activist investor focused on U.S. listed stocks in the U.S. and in China. He was previously an investment banker in one of Wall Street's largest investment banks for nearly a decade, stationed between New York, Hong Kong and London. As a director in equity capital markets he oversaw over $30 billion in equity and equity linked transactions, primarily for health care and technology companies.
Pearson spends his time living between Los Angeles and Beijing. He has a degree in finance from the University of Southern California and has studied Mandarin since 1991.
The Chinese pork producer needs to clear up discrepancies to regain investors' trust.
After a weeklong evaluation of China Biotics, Rick Pearson has decided to stay short on the company's stock.
A purchase by a large investor has instilled confidence in the company. But the story doesn't add up.
A Chinese miner is the latest example of a shaky company without much of a future.
Institutions' stakes in China small-caps can be misleading to the average investor.
Rick Pearson explains why his visit to the SCEI facility did not lead to an investment.
Another risk of investing in China small-caps is watching your money tied up while fraud allegations are sorted.
Small-cap stocks are more prone to be moved by rumors simply because they receive less mainstream coverage than larger-cap stocks.
Serious fraud allegations at Longtop Financial have raised concerns that fraud among U.S.-listed Chinese companies extends beyond just RTOs to major IPOs as well.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.